[go: up one dir, main page]

MX2012001767A - Intervenciones de urgencia de carbon vegetal activo con. - Google Patents

Intervenciones de urgencia de carbon vegetal activo con.

Info

Publication number
MX2012001767A
MX2012001767A MX2012001767A MX2012001767A MX2012001767A MX 2012001767 A MX2012001767 A MX 2012001767A MX 2012001767 A MX2012001767 A MX 2012001767A MX 2012001767 A MX2012001767 A MX 2012001767A MX 2012001767 A MX2012001767 A MX 2012001767A
Authority
MX
Mexico
Prior art keywords
segment
query
update operations
storage node
batch
Prior art date
Application number
MX2012001767A
Other languages
English (en)
Inventor
Andreas Clemens
Joanne Van Ryn
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of MX2012001767A publication Critical patent/MX2012001767A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/44—Elemental carbon, e.g. charcoal, carbon black
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)

Abstract

La invención se refiere a un método para tratar una sobredosificación con la sustancia activa etexilato de dabigatrán de fórmula I (ver fórmula (I)) opcionalmente en forma de sus sales farmacéuticamente aceptables, que comprende la administración de una cantidad eficaz de carbón vegetal.
MX2012001767A 2009-08-24 2010-08-23 Intervenciones de urgencia de carbon vegetal activo con. MX2012001767A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23632109P 2009-08-24 2009-08-24
PCT/EP2010/062229 WO2011023653A1 (en) 2009-08-24 2010-08-23 Emergency interventions of active charcoal with dabigatran etexilate overdosing

Publications (1)

Publication Number Publication Date
MX2012001767A true MX2012001767A (es) 2012-02-29

Family

ID=42740360

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012001767A MX2012001767A (es) 2009-08-24 2010-08-23 Intervenciones de urgencia de carbon vegetal activo con.

Country Status (20)

Country Link
US (2) US20110206656A1 (es)
EP (1) EP2470187B1 (es)
JP (1) JP2013502449A (es)
KR (1) KR20120050457A (es)
CN (1) CN102481317B (es)
AR (1) AR077909A1 (es)
AU (1) AU2010288601A1 (es)
BR (1) BR112012004169A2 (es)
CA (1) CA2767966A1 (es)
CL (1) CL2012000488A1 (es)
DK (1) DK2470187T3 (es)
EA (1) EA201200319A1 (es)
ES (1) ES2436076T3 (es)
IL (1) IL216968A0 (es)
MX (1) MX2012001767A (es)
NZ (1) NZ597359A (es)
PH (1) PH12012500388A1 (es)
PL (1) PL2470187T3 (es)
TW (1) TW201124143A (es)
WO (1) WO2011023653A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI513466B (zh) 2010-01-20 2015-12-21 Boehringer Ingelheim Int 抗凝血劑解毒劑
PH12013501924A1 (en) * 2011-03-30 2017-10-25 Boehringer Ingelheim Int Anticoagulant antidotes
GB201120693D0 (en) * 2011-12-01 2012-01-11 Convatec Technologies Inc Wound dressing for use in vacuum therapy
CN114452839B (zh) * 2022-02-10 2023-04-21 中南大学湘雅医院 一种抗凝抗栓血液净化膜及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5277820A (en) * 1992-02-06 1994-01-11 Hemocleanse, Inc. Device and method for extracorporeal blood treatment
PE121699A1 (es) 1997-02-18 1999-12-08 Boehringer Ingelheim Pharma Heterociclos biciclicos disustituidos como inhibidores de la trombina
NZ535663A (en) 2002-03-07 2006-06-30 Boehringer Ingelheim Pharma Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino] propionic acid ethyl ester and the salts thereof

Also Published As

Publication number Publication date
IL216968A0 (en) 2012-02-29
KR20120050457A (ko) 2012-05-18
US20130302311A1 (en) 2013-11-14
US20110206656A1 (en) 2011-08-25
AU2010288601A1 (en) 2012-02-02
CL2012000488A1 (es) 2012-08-31
EP2470187B1 (en) 2013-08-21
NZ597359A (en) 2014-01-31
AR077909A1 (es) 2011-09-28
DK2470187T3 (da) 2013-10-28
PL2470187T3 (pl) 2014-01-31
EA201200319A1 (ru) 2012-09-28
EP2470187A1 (en) 2012-07-04
PH12012500388A1 (en) 2012-10-22
ES2436076T3 (es) 2013-12-26
BR112012004169A2 (pt) 2016-03-29
CA2767966A1 (en) 2011-03-03
JP2013502449A (ja) 2013-01-24
WO2011023653A1 (en) 2011-03-03
CN102481317A (zh) 2012-05-30
TW201124143A (en) 2011-07-16
CN102481317B (zh) 2014-09-03

Similar Documents

Publication Publication Date Title
WO2011023652A3 (en) Continuous full scan data store table and distributed data store featuring predictable answer time for unpredictable workload
Shukla et al. Intraperitoneal bupivacaine alone or with dexmedetomidine or tramadol for post-operative analgesia following laparoscopic cholecystectomy: A comparative evaluation
MX2012001767A (es) Intervenciones de urgencia de carbon vegetal activo con.
Gupta et al. Systematic review of oral treatments for seborrheic dermatitis
CA3043681A1 (en) Combination of an egfr t790m inhibitor and a cdk inhibitor for the treatment of non-small cell lung cancer
RU2018138028A (ru) Производные 2,3-дигидро-изоиндол-1-она и способы их применения в качестве ингибиторов тирозинкиназы брутона
WO2016034079A1 (zh) 一种gabaa受体增强剂用于制备镇静麻醉的药物中的用途
Zhang et al. EC50 of epidural ropivacaine combined with dexmedetomidine for labor analgesia
Xiang et al. Effect of oxycodone hydrochloride combined with flurbiprofen axetil for intravenous patient-controlled analgesia in lower abdominal patients: a randomized trial
Akan et al. Comparison of levobupivacaine alone and in combination with fentanyl and sufentanil in patients undergoing transurethral resection of the prostate
Parikh et al. Preventive analgesia: Effect of small dose of ketamine on morphine requirement after renal surgery
Joseph et al. Premedication with gabapentin, alprazolam or a placebo for abdominal hysterectomy: Effect on pre-operative anxiety, post-operative pain and morphine consumption
CN103536613B (zh) 一种抗真菌的药物组合物
AR043822A1 (es) Formas de dosificacion y procedimientos de tratamiento que usan inhibidores del vegfr
NZ630488A (en) Piperidine derivatives for gpr119 agonist
Bandey et al. Comparison between IV paracetamol and tramadol for postoperative analgesia in patients undergoing laparoscopic cholecystectomy
Shi et al. Intraoperative use of dexmedetomidine promotes postoperative sleep and recovery following radical mastectomy under general anesthesia
Ipe et al. A comparative study of intrathecal and epidural buprenorphine using combined spinal-epidural technique for caesarean section
Bharti et al. Efficacy of intrathecal midazolam versus fentanyl for endoscopic urology surgery
EP4279138A3 (en) Crystal of compound as c-met kinase inhibitor and preparation method therefor and use thereof
RU2500101C1 (ru) Способ воспроизводства осетровых рыб
RU2011149160A (ru) СОЛИ МЕТИЛ(R)-7-[3-АМИНО-4-(2,4,5-ТРИФТОРФЕНИЛ)-БУТИРИЛ]-3-ТРИФТОРМЕТИЛ-5,6,7,8-ТЕТРАГИДРО-ИМИДАЗО[1,5-a]ПИРАЗИН-1-КАРБОКСИЛАТА
SG11201810800VA (en) Crystalline form of compound suppressing protein kinase activity, and application thereof
CN104644635A (zh) 一种沃替西汀药物组合物及其制备方法
RU2016109792A (ru) Новые соединения-антагонисты рецептора нейрокинина-1

Legal Events

Date Code Title Description
FG Grant or registration